- Supported exchanges /
- AU /
- FRE.AU
Firebrick Pharma Ltd (FRE AU) stock market data APIs
A$0.054
-0(-0%)
as of September 19, 2024
Price chart is built with Anychart
Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Firebrick Pharma Ltd Financial Data Overview
| 0.056 | |
| 0.054 | |
| - | |
| 0.056 | |
| 0.054 | |
| 0.036-0.11 | |
| 10 762 K | |
| 196 M | |
| 2 750 K | |
| -0.02 | |
| 1.682 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'FRE',
Type:
'Common Stock',
Name:
'Firebrick Pharma Ltd',
Exchange:
'AU',
CurrencyCode:
'AUD',
CurrencyName:
'Australian Dollar',
CurrencySymbol:
'A$',
CountryName:
'Australia',
CountryISO:
'AU',
OpenFigi:
'BBG0140SS6L1',
ISIN:
'AU0000197352',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'June',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - General',
}
Firebrick Pharma Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 750 K
- EBITDA -1 084 695
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Firebrick Pharma Ltd Earnings via APIs
- Latest Release 2023-02-17
- EPS/Forecast 0
Get Firebrick Pharma Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
